QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 7 August 2019Portfolio NewsQ&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.
- 22 July 2019Portfolio NewsWashington Regional and Urgent Team Family of Urgent Care Join Forces
- 17 July 2019Portfolio NewsKarus Therapeutics Strengthens Clinical Leadership Team with Appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer
- 8 July 2019Portfolio NewsDDF notes MedaRed Raises $6.5 Million Financing with Investment from DDF
- 2 July 2019SV NewsDDF notes the appointment of Jonathan Behr, PhD as Partner
- 29 June 2019SV NewsHow to spot the hidden gem investment funds
- 29 May 2019Portfolio NewsTiaki Therapeutics, a DDF-formed company, announces collaboration with Eisai
- 28 May 2019Portfolio NewsCardioFocus Raises $55M in Financing
- 28 May 2019Portfolio NewsCardioFocus lands $55M in funding for product launches
- 22 May 2019Portfolio NewsBicycle Therapeutics Announces Pricing of Initial Public Offering
- 8 May 2019Portfolio NewsJet Health, Inc. Acquires Boise, Idaho-Based First Choice Home Health and Hospice; Marks Company's Entry into Hospice Arena
- 7 May 2019Portfolio NewsDDF to collaborate with Bicycle Therapeutics